CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Worldwide, over 10 million people are killed or hospitalized because of traumatic brain injury each year. About 90% of deaths occur in low- and middle-income countries. The condition mostly affects young adults, and many experience l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dewan Yashbir, Komolafe Edward O, Mejía-Mantilla Jorge H, Perel Pablo, Roberts Ian, Shakur Haleema
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2012-06-01
Saila:Trials
Gaiak:
Antifibrinolytic
Clinical trial
Emergency care
Intracranial bleeding
Tranexamic acid
Traumatic brain injury
Sarrera elektronikoa:http://www.trialsjournal.com/content/13/1/87
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak